Literature DB >> 11532744

Drug use and life style among college undergraduates: a 30-year longitudinal study.

H G Pope1, M Ionescu-Pioggia, K W Pope.   

Abstract

OBJECTIVE: The authors examined trends in the prevalence of substance use and its relationship to attributes of life style among college students over a 30-year period.
METHOD: They distributed anonymous questionnaires to 796 seniors at a large New England college in 1999, using methods essentially identical to those of their previous studies at the same college in 1969, 1978, and 1989.
RESULTS: Most forms of drug use rose to a peak in 1978 then fell over the next 21 years, except for use of 3,4-methylenedioxymethamphetamine ("ecstasy"). On several variables, college substance users differed more sharply from nonusers in 1999 than in previous decades.
CONCLUSIONS: Although the study was limited to students at a single institution, its findings suggest that college drug use is generally declining and that users have increasingly diverged from nonusers in their values and life style.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11532744     DOI: 10.1176/appi.ajp.158.9.1519

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  24 in total

Review 1.  Hallucinogens: an update.

Authors:  John H Halpern
Journal:  Curr Psychiatry Rep       Date:  2003-10       Impact factor: 5.285

2.  Correlates of African American female adolescent offenders 3, 4-Methylenedioxymethamphetamine (MDMA or "Ecstasy") use and sexually transmitted infection morbidity.

Authors:  Torrance Stephens; Rhonda Conerly Holliday; Shakita Hopkins; Shanhol Rose; Ronald Braithwaite; Selina Smith
Journal:  J Hum Behav Soc Environ       Date:  2015-09-29

3.  The effect of substance abuse treatment on Medicaid expenditures among general assistance welfare clients in Washington state.

Authors:  Thomas M Wickizer; Antoinette Krupski; Kenneth D Stark; David Mancuso; Kevin Campbell
Journal:  Milbank Q       Date:  2006       Impact factor: 4.911

Review 4.  A developmental comparison of the neurobehavioral effects of ecstasy (MDMA).

Authors:  Brian J Piper
Journal:  Neurotoxicol Teratol       Date:  2006-10-20       Impact factor: 3.763

5.  Sensitizing regimens of (+/-)3, 4-methylenedioxymethamphetamine (ecstasy) elicit enduring and differential structural alterations in the brain motive circuit of the rat.

Authors:  K T Ball; C L Wellman; E Fortenberry; G V Rebec
Journal:  Neuroscience       Date:  2009-02-21       Impact factor: 3.590

6.  Intracranial self-administration of MDMA into the ventral striatum of the rat: differential roles of the nucleus accumbens shell, core, and olfactory tubercle.

Authors:  Rick Shin; Mei Qin; Zhong-Hua Liu; Satoshi Ikemoto
Journal:  Psychopharmacology (Berl)       Date:  2008-04-05       Impact factor: 4.530

7.  Is ecstasy MDMA? A review of the proportion of ecstasy tablets containing MDMA, their dosage levels, and the changing perceptions of purity.

Authors:  A C Parrott
Journal:  Psychopharmacology (Berl)       Date:  2004-03-09       Impact factor: 4.530

8.  Development, maintenance and temporal pattern of self-administration maintained by ecstasy (MDMA) in rats.

Authors:  Susan Schenk; David Gittings; Malcolm Johnstone; Evangeline Daniela
Journal:  Psychopharmacology (Berl)       Date:  2003-05-28       Impact factor: 4.530

9.  DNA damage and ubiquitinated neuronal inclusions in the substantia nigra and striatum of mice following MDMA (ecstasy).

Authors:  F Fornai; P Lenzi; G Frenzilli; M Gesi; M Ferrucci; G Lazzeri; F Biagioni; M Nigro; A Falleni; M Giusiani; A Pellegrini; F Blandini; S Ruggieri; A Paparelli
Journal:  Psychopharmacology (Berl)       Date:  2003-12-13       Impact factor: 4.530

10.  Sex differences in psychosocial correlates of concurrent substance use among heterosexual, homosexual and bisexual college students.

Authors:  Gillian L Schauer; Carla J Berg; Lawrence O Bryant
Journal:  Am J Drug Alcohol Abuse       Date:  2013-06-17       Impact factor: 3.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.